<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                               NIH Public Access <br />                                Author Manuscript <br />                                Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                            Published final edited form  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Mol Biochem Parasitol. 2007 December ; 156(2): 246&#226;&#8364;&#8220;254. doi:10.1016/j.molbiopara.2007.09.001. <br />  <br />  <br />  <br />                            Evidence capping enzyme specificity                            trypanosome spliced leader RNA <br />  <br />                            Jia-peng Ruana, Shuiyuan Shenb, Elisabetta Ullub,c, Christian Tschudia,b,* <br />                            Department Epidemiology <span id='am-26' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-27' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-29' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-30' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span>amp</span>; Public Health, Yale University Medical School, 295 Congress Avenue, New <br />  <br />                            Haven, CT 06536-0812, USA <br />                            bDepartment Internal Medicine, Yale University Medical School, 295 Congress Avenue, New Haven, CT <br />                            06536-0812, USA <br />                            cDepartment Cell Biology, Yale University Medical School, 295 Congress Avenue, New Haven, CT <br />                            06536-0812, USA <br />  <br />                            Abstract <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  Capping pre-mRNA 5&#226;&#8364;&#178; end addition monomethylated <span id='am-33' about='obo:IMR_0200445' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001697 obo:IMR_0000001 obo:IMR_0001698'><span id='am-34' property="oboInOwl:hasDbXref" content="KEGG:C00387" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-36' property="rdfs:label" content="guanosine" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:id" content="IMR:0200445" datatype="xsd:string"></span>guanosine</span> cap (m7G) essential <br />                                  earliest modification biogenesis mRNA. reaction catalyzed enzymes: <br />                                  triphosphatase, guanylyltransferase, (<span id='am-115' about='obo:IMR_0200319' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-116' property="rdfs:label" content="Guanine" datatype="xsd:string"></span><span id='am-117' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-118' property="oboInOwl:hasDbXref" content="KEGG:C00242" datatype="xsd:string"></span><span id='am-119' property="oboInOwl:id" content="IMR:0200319" datatype="xsd:string"></span>guanine</span> N-7) methyltransferase. modification <br />                                  occurs transcriptionally eukaryotic organisms, trypanosomatid protozoa mRNAs acquire <br />                                  m7G cap trans-splicing, entails transfer capped spliced leader (SL)                                  SL RNA mRNA. Intriguingly, genomes trypanosomatid protozoa sequenced <span id='am-14' about='oboInOwl:date' typeof='owl:Thing'>date</span> <br />                                  possess distinct proteins signature motifs guanylyltransferases: TbCGM1                                  previously characterized TbCE1. provide biochemical evidence TbCgm1 capping <br />                                  enzyme. RNAi-induced downregulation TbCe1 phenotypic consequences,                                  TbCGM1 essential trypanosome viability required SL RNA capping. <br />                                  Furthermore, consistent transcriptional addition m7G cap, chromatin <br />                                  immunoprecipitation revealed recruitment TbCgm1 SL RNA genes. <br />  <br />  <br />                            Keywords <br />                                  mRNA capping; guanylyltransferase; cap 4 modification; trans-splicing; SL RNA; RNAi <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            1. Introduction <br />                                               eukaryotic cells analyzed far, including Trypanosoma brucei, addition m7G cap <br />                                               represents earliest event modification 5&#226;&#8364;&#178; end RNA polymerase II (pol II) <br />                                               transcripts [1&#226;&#8364;&#8220;3]. Capping occurs transcriptionally RNA achieved chain <br />                                               length 30 nucleotides (nt). Formation m7GpppN cap entails enzymatic <br />                                               reactions [4]. 5&#226;&#8364;&#178; <span id='am-54' about='obo:IMR_0200358' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-55' property="oboInOwl:hasDbXref" content="KEGG:C00536" datatype="xsd:string"></span><span id='am-56' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-57' property="rdfs:label" content="Triphosphate" datatype="xsd:string"></span><span id='am-58' property="oboInOwl:id" content="IMR:0200358" datatype="xsd:string"></span>triphosphate</span> end hydrolyzed RNA 5&#226;&#8364;&#178; triphosphatase 5&#226;&#8364;&#178; <br />                                               diphosphate, capped <span id='am-109' about='obo:IMR_0200292' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-110' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-111' property="oboInOwl:hasDbXref" content="KEGG:C00144" datatype="xsd:string"></span><span id='am-112' property="rdfs:label" content="GMP" datatype="xsd:string"></span><span id='am-113' property="oboInOwl:id" content="IMR:0200292" datatype="xsd:string"></span>GMP</span> RNA guanylyltransferase. Finally,                                               guanosine moiety GpppN cap methylated RNA (guanine-N7) methyltransferase. <br />                                               cap-forming activities essential budding yeast [5&#226;&#8364;&#8220;7]. <br />  <br />  <br />                            *Corresponding author: Tel.: +1-203-7857332; Fax +1-203-7857329; E-mail address: E-mail: christian.tschudi@yale.edu. <br />                            Publisher&apos;s Disclaimer: PDF file unedited manuscript accepted publication. service customers <br />                            providing early version manuscript. manuscript undergo copyediting, typesetting, review resulting <br />                            proof published final citable form. note production process errors discovered                            affect content, legal disclaimers apply journal pertain. <br />                             Ruan et al.                                                                                               Page 2 <br />  <br />  <br />                                          eukaryotes depend enzymatic reactions m7G capping,                                          physical organization capping apparatus quite diverse different organisms [4,8,9]. <br />                                          component capping enzyme consisting bifunctional triphosphatase- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          guanylyltransferase polypeptide separate methyltransferase polypeptide present                                          metazoans plants. contrast, fungi microsporidia Encephalitozoon cuniculi                                          component separate triphosphatase, guanylyltransferase                                          methyltransferase polypeptides. protozoa Plasmodium falciparum [10] Giardia <br />                                          lamblia [11] yeast-like machinery. Extensive mutational analysis crystal structures <br />                                          revealed RNA guanylyltransferases related DNA RNA ligases [4,8,9]                                          structurally mechanistically conserved eukaryotic species viruses. <br />                                          Guanylyltransferases catalyze nucleotidyl transfer covalent enzyme-(lysyl-N)- <br />                                          GMP intermediate defined set conserved signature motifs [12].                                          hand, RNA triphosphatases fall mechanistically structurally distinct <br />                                          families. Triphosphatases fungi, microsporidia, protozoa, including T. brucei,                                          Chlorella virus belong family metal-dependant NTP phosphohydrolases defined                                          unique active site tunnel architecture [13,14], metazoan plant triphosphatases <br />                                          cysteine phosphatase superfamily [15,16]. crystal structure (guanine- <br />                                          N7) methyltransferase E. cuniculi highlighted known biochemical specificity                                          enzyme [17] completed catalogue protein structures enzymes required <br />                                          m7GpppN cap formation. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          eukaryotic organisms m7G capping restricted nascent pol II transcripts. contrast, <br />                                          studies trypanosomatid protozoa highlighted peculiar aspect mode cap <br />                                          formation, modification present pol II-transcribed spliced leader <br />                                          (SL) RNA, specific subset pol III transcripts, U1, U2,                                          U4 snRNAs U3 snoRNA. abundant pol III transcripts (tRNAs, 5S rRNA <br />                                          7SL RNA) capped, raises numerous questions specificity                                          regulation capping mechanism. Furthermore, mRNA cap addition occurs post- <br />                                          transcriptional trans-splicing, entails transfer 39-nt long SL sequence, <br />                                          including cap structure, SL RNA 5&#226;&#8364;&#178; end mRNAs [18&#226;&#8364;&#8220;20]. SL <br />                                          RNA cap unique trypanosomatids contains hypermodified cap 4 structure,                                          derived methylation seven sites nucleotides SL RNA <br />                                          resulting structure: m7guanosine-ppp-N6,N6,2&#226;&#8364;&#178;-O-trimethyladenosine-p-2&#226;&#8364;&#178;-O- <br />                                          methyladenosine-p-2&#226;&#8364;&#178;-O-methylcytosine-p-N3,2&#226;&#8364;&#178;-O-methyluridine [21]. Recently, 2&#226;&#8364;&#178;-O- <br />                                          methyltransferases required cap 4 biogenesis identified shown                                          intriguingly similar vaccinia virus VP39 [22&#226;&#8364;&#8220;25]. addition, cap 4 structure T. <br />                                          brucei specifically recognized unusual nuclear cap binding complex contains                                          novel essential subunits present trypanosomatids [26]. Taken                                          observations underscore uniqueness capping apparatus trypanosomatid protozoa. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          initial characterization enzymatic machinery involved m7G capping                                          trypanosomatids identified polypeptide Crithidia fasciculata T. brucei (Ce1)                                          structural biochemical properties characteristic <span id='am-6' about='obo:IMR_0001354' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-7' property="oboInOwl:hasDbXref" content="KEGG:C00044" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="GTP" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:id" content="IMR:0001354" datatype="xsd:string"></span><span id='am-11' property="rdfs:label" content="guanosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasAlternativeId" content="IMR:0200086" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasExactSynonym" content="guanosine 5&apos;-triphosphate" datatype="xsd:string"></span>GTP</span>:RNA guanylyltransferases [27]. <br />                                          carboxy-terminal half Ce1 displays signature motifs characteristic                                          guanylyltransferases, amino-terminal half contains domain unknown function                                          resemblance domain associated capping enzymes. course                                          studies, noted second polypeptide C. fasciculata T. brucei extracts approximately <br />                                          116 kDa, capable forming covalent protein-GMP complex, indicative capping <br />                                          enzyme.  characterization polypeptide pursued                                           recently, RNA triphosphatase (TbCet1) characterized T. brucei, structurally <br />                                          mechanistically related fungal metal-dependent phosphohydrolases [28],                                          recombinant T. brucei Cmt1 shown (guanine-N7) methyltransferase [29].                                          addition, data-base mining identified second candidate T. brucei capping enzyme, TbCgm1, <br />  <br />  <br />                                            Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                            Page 3 <br />  <br />  <br />                                           predicted N-terminal guanylyltransferase domain C-terminal methyltransferase <br />                                           domain [29]. manuscript preparation, Ho laboratory reported                                           TbCgm1 caps SL RNA [30]. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            used RNA interference-induced regulation, biochemical properties                                           chromatin immunoprecipitation examine vivo function T. brucei capping <br />                                           enzymes TbCe1 TbCgm1 interface unusual capping pol II <br />                                           pol III transcripts. <br />  <br />                               2. Materials methods <br />                               2.1. Plasmids, transfections RNAi <br />                                           PCR products encompassing nt 1 - 894 N-terminal domain TbCE1, nt 180 - 1,180 <br />                                           guanylyltransferase domain TbCGM1 inserted sense antisense <br />                                           orientation separated stuffer fragment plasmid pLEW100 [31] transfected                                           procyclic T. brucei strain 29.13.6 [32], harbors integrated genes T7 RNA <br />                                           polymerase tetracycline repressor. cells selected phleomycin cloned <br />                                           96 plates. Clonal cell lines induced adding tetracycline concentration                                           10 &#206;&#188;g/ml. PCR-based approach [33] used introduce BB2 epitope tag N- <br />                                           terminus TbCe1 TbCgm1 replace second allele blasticidin (BSR) <br />                                           resistant gene. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           produce recombinant guanylyltransferase E. coli, nt 1- 2,355 TbCGM1, corresponding <br />                                           amino acids 1 - 785, cloned NotI XhoI restriction sites T7 <br />                                           RNA polymerase-based expression vector pET-44a (Novagen). lysine residue motif                                           changed alanine step PCR procedure mutation verified DNA <br />                                           sequencing. <br />  <br />                               2.2. RNA analysis <br />                                           RNA extraction Northern blot analysis performed described [34]. Figure 3B, <br />                                           4B 4C, SL RNA primer extended oligonucleotide Y-21, complementary                                           nt 40 60, Figure 4D SLIN22, complementary nt 110 131, used. U2, U3                                           U6 snRNAs primed oligonucleotide U2B-17, complementary nt 46 62, U3-PE, <br />                                           complementary nt 96 123, U6-22, complementary nt 19 40, respectively. <br />  <br />                                           Total RNA subjected immunoprecipitations rabbit polyclonal antibodies                                           m7G cap  kind gift Dr. F. Richards) mouse monoclonal antibodies                                           2,2,7-trimethylguanosine cap (Calbiochem). RNA samples analyzed primer extension. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Uninduced TbCGM1 RNAi-induced procyclic T. brucei cells permeabilized                                           lysolecithin (L-&#206;&#177;-lysophosphatidylcholine, palmitoyl, Sigma) RNA synthesized                                           15 minutes presence [&#206;&#177;-32P]GTP [&#206;&#177;-32P]<span id='am-38' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-39' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-40' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-43' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-48' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span>ATP</span> described [3,35,36]. Total RNA, <br />                                           extracted TRIZOL reagent, separated 6% polyacrylamide - 7M <span id='am-120' about='obo:IMR_0200111' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-121' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-122' property="oboInOwl:id" content="IMR:0200111" datatype="xsd:string"></span><span id='am-123' property="oboInOwl:hasDbXref" content="KEGG:C00086" datatype="xsd:string"></span><span id='am-124' property="rdfs:label" content="Urea" datatype="xsd:string"></span>urea</span> gels, SL <br />                                           RNA excised eluted water. Tobacco acid pyrophosphatase (TAP) cleavage                                           nuclease P1 digestion essentially described [3] digestion products                                           chromatographed Avicel cellulose layer plates, developed isobutyric acid/ <br />                                           concentrated NH4OH/<span id='am-49' about='obo:IMR_0200357' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-50' property="oboInOwl:id" content="IMR:0200357" datatype="xsd:string"></span><span id='am-51' property="oboInOwl:hasDbXref" content="KEGG:C00001" datatype="xsd:string"></span><span id='am-52' property="rdfs:label" content="H2O" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>H2O</span>, 66:1:33 (v/v/v). <br />  <br />                               2.3. procedures <br />                                           GMP binding [27] ChIP previously described [37]. <br />  <br />  <br />  <br />  <br />                                             Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                                Page 4 <br />  <br />  <br />                               3. Results <br />                               3.1. guanylyltransferase domain TbCgm1 binds GMP <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            search T. brucei databases additional components capping machinery, <br />                                            [29] predicted protein, TbCgm1, 116,820 Da (GeneDB accession # <br />                                            Tb927.7.2080) convincing homologies RNA (guanine-N7) methyltransferases                                            C-terminal half protein. domain motif searches revealed N-terminal <br />                                            half characteristics guanylyltransferase domain <span id='am-1' about='obo:IMR_0001700' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="obo:IAO_0000115" content="The polypeptide that is not a gene product." datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="peptide" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:id" content="IMR:0001700" datatype="xsd:string"></span>peptide</span> motifs                                            absolutely conserved superfamily capping enzymes DNA ligases constitute <br />                                            active site GMP binding nucleotidyl transfer [4,29]. Northern blot, 5&#226;&#8364;&#178; end RACE <br />                                            sequencing cDNA clones established authenticity gene T. brucei <br />                                            genome determined structure mRNA 5&#226;&#8364;&#178; end (data shown). <br />  <br />                                            identification second putative guanylyltransferase domain eukaryotic organism <br />                                            unique.  finding rationalized earlier observation T. brucei <br />                                            cell extracts polypeptides 67 116 kDa capable forming covalent <br />                                            GMP-enzyme complex characteristic capping enzymes [27]. 67 kDa- <br />                                            polypeptide (TbCe1) shown functional guanylyltransferase domain, larger <br />                                            polypeptide pursued  view predicted molecular weight 117 kDa                                            presence putative N-terminal guanylyltransferase domain, TbCgm1 likely <br />                                            candidate second GMP-binding enzyme. test TbCGM1 encoded protein <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            bind GMP covalent fashion, initially expressed length TbCgm1                                            Escherichia coli different expression vectors, did result                                            production sufficient quantities recombinant protein soluble form perform <br />                                            enzymatic tests.  generated construct containing 785 amino acids TbCgm1 <br />                                            fused N-terminus E. coli NusA protein. 142 kDa protein corresponding                                            fusion protein detectable SDS-PAGE soluble extracts IPTG-induced bacteria <br />                                            (upper panel Fig. 1, lane 2). recombinant protein formed SDS-stable <span id='am-59' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-60' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-61' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-62' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-63' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-64' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-65' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-66' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span>nucleotide</span>- <br />                                            protein adduct (lower panel Fig. 1, lane 2), evident sample expressing <br />                                            NusA protein (lane 1). Importantly, protein lost ability bind GMP,                                            predicted catalytic lysine residue (<span id='am-72' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-73' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-74' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-75' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-76' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-77' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-78' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span>amino acid</span> 127) motif mutated alanine (lane 3), <br />                                            providing evidence TbCgm1 functional guanylyltransferase domain. <br />  <br />                               3.2. TbCgm1 encoded essential gene <br />                                            begin investigate vivo function T. brucei polypeptides containing <br />                                            guanylyltransferase domains, used RNA interference (RNAi) downregulate                                            respective mRNAs.  nt 1 - 894 TbCE1 nt 180 - 1,180 TbCGM1                                            inserted sense antisense orientation separated spacer fragment plasmid <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            pLEW100 [38]. cassette, driven tetracycline (tet) inducible ribosomal promoter,                                            stably integrated non-transcribed rDNA spacer region clonal cell lines                                            established. RNAi induction tet, production double-stranded RNA                                            degradation target mRNA verified Northern blot (data shown). addition, <br />                                            extracts prepared CE1-RNAi cell lines induced 24 hr GMP-enzyme complex <br />                                            formation reduced undetectable levels (Fig. 2A), CGM1-RNAi cell lines                                            Cgm1 protein severely decreased, albeit detectable 24 hr (Fig. 2B). Importantly, <br />                                            results Figures 2A B demonstrated specificity downregulation Ce1                                            Cgm1 corresponding RNAi construct.  monitored cell growth period                                            4 days (Fig. 2C). Compared wild-type uninduced cells, downregulation TbCE1                                            noticeable effect cell viability. fact, maintaining induction 10 days did <br />                                            reveal detectable change growth characteristics. contrast, monitoring cell growth <br />                                            TbCGM1 RNAi induction revealed growth rate declined day 2 day <br />                                            3 eventually cells died (Fig. 2C), indicating TbCGM1 essential viability. <br />  <br />  <br />                                              Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                              Page 5 <br />  <br />  <br />                               3.3. Depletion TbCE1 TbCGM1 does affect capping U2 snRNA U3 snoRNA <br />                                           Similar eukaryotes, trypanosomatid U1, U2 U4 snRNAs U3 snoRNA <br />                                           contain 2,2,7-trimethylguanosine (TMG) cap [39&#226;&#8364;&#8220;41]. Little known sequence NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           events leading TMG cap trypanosomatids, presumed RNA molecules <br />                                           initially modified m7G cap [42,43].  set experiments, asked <br />                                           TbCE1 TbCGM1 downregulation effect cap formation U2 snRNA <br />                                           U3 snoRNA. TbCE1-RNAi cells induced tet 8 days, RNA prepared <br />                                           assayed immunoprecipitation anti-m7G anti-TMG antibodies followed                                           primer extension analysis (Fig. 3A). expected, U2 U3 RNAs affinity selected <br />                                           anti-TMG antibodies RNA prepared uninduced cells (Fig. 3A, lane 5),                                           RNAs detectable anti-m7G immunoprecipitate (lane 3). similar result <br />                                           obtained RNA isolated TbCE1-RNAi cells induced 8 days (lanes 8 10). <br />                                           Furthermore, detectable difference uninduced TbCGM1-RNAi cells                                           cells induced 2.5 days (Fig. 4A, compare lanes 2 5 lanes 7 10), indicating                                           cap formation U2 snRNA U3 snoRNA appeared normal conditions                                           TbCe1 TbCgm1 protein amounts limiting. <br />  <br />                               3.4. TbCgm1 involved SL RNA capping <br />                                           investigated RNAi-induced downregulation TbCE1 TbCGM1 affected <br />                                           cap formation pol II-transcribed SL RNA. RNA prepared TbCE1-RNAi cells <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           induced 2.5 8 days assayed primer extension analysis SL RNA (Fig. 3B). <br />                                           shown previously [22,44] evident Figure 3B (lane 2), primer extension analysis                                           low deoxyribonucleotide triphosphate concentrations gives rise characteristic primer <br />                                           extension stop 5&#226;&#8364;&#178; end SL RNA indicative fully-methylated cap 4 structure <br />                                           (indicated fm SL). contrast, hypomethylated SL RNA (hm SL) prepared cells grown <br />                                           presence methylation inhibitor sinefungin, gives rise series bands <br />                                           characteristic SL RNA partially methylated cap 4 (Fig. 3B, lane 1). TbCE1 <br />                                           downregulation 8 days did affect accumulation methylation status SL RNA, <br />                                           assayed primer extension analysis (Fig. 3B, compare lanes 2 4). contrast, following <br />                                           2 2.5 days induction TbCGM1 RNAi, accumulation SL RNA reduced <br />                                           76% 36%, respectively, compared uninduced cells (Fig. 4B). addition, clear <br />                                           defect cap 4 formation evident fully-modified SL RNA reduced 34% 13% <br />                                           day 2 2.5, respectively, concomitant appearance longer extension products <br />                                           indicative SL RNA carrying hypomethylated cap 4 (lanes 4 5). <br />  <br />                                           address apparent effect TbCGM1 downregulation SL RNA cap formation                                            used immunoprecipitation anti-m7G antibodies (Fig. 4C).                                           majority fully-modified SL RNA affinity selected RNA isolated NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           uninduced cells (lane 3), 2.5 days induction hypomethylated SL RNA                                           predominantly supernatant (compare lanes 5 6). contrast, small                                           fully-modified SL RNA present 2.5 days induction immunoprecipitated                                           anti-m7G antibodies (lane 6).  epitope recognized antibody present                                           considerable proportion steady-state SL RNA accumulating downregulation                                           Cgm1, suggesting defect m7G cap. <br />  <br />                                            turned analysis newly-synthesized RNA permeabilized T. brucei cells. <br />                                           Uninduced TbCGM1-RNAi cells induced 1 2.5 days permeabilized                                           lysolecithin incubated 15 min transcription cocktail containing [&#206;&#177;-32P]GTP [35]. <br />                                           Using number cells permeabilization procedure, obvious <br />                                           difference total RNA synthesis induced cells, compared uninduced cells (data <br />                                           shown). SL RNA gel purified digested tobacco acid pyrophosphatase <br />                                           (TAP), released cap nucleotide SL RNA hydrolyzing <span id='am-21' about='obo:IMR_0200280' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-22' property="oboInOwl:hasDbXref" content="KEGG:C00013" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:id" content="IMR:0200280" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-25' property="rdfs:label" content="Pyrophosphate" datatype="xsd:string"></span>pyrophosphate</span> <br />  <br />  <br />                                             Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                               Page 6 <br />  <br />  <br />                                           bond. digestion products separated layer chromatography (TLC) analyzed <br />                                           phosphorimaging (Fig. 5A). treatment released 1.5% radioactive <span id='am-114' about='rdfs:label' typeof='owl:Thing'>label</span> SL <br />                                           RNA uninduced cells form m7G (lane 1). value did change 1 day <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           TbCGM1 depletion (lane 2, 1.5%), reduced 0.8% following 2.5 days induction <br />                                           (lane 3). uninduced (lane 1) 1 day-induced cells (lane 2) 0.8% radioactive label <br />                                           released TAP form GMP, indicative cap methyl group                                           N7 position guanosine. value increased 1.4% sample isolated cells <br />                                           induced 2.5 days (lane 3). addition, new spot (1.5% radioactive label) <br />                                           did correspond available standards (labeled X1 Fig. 5A).  <br />                                           dimensional TLC analysis (data shown) failed clues possible nature                                           X1 spot.  data agreement immunoprecipitation results <br />                                           anti-m7G antibodies indicated CGM1 silencing increase <br />                                           proportion SL RNA bearing unmethylated cap structure. <br />  <br />                                           define consequences TbCgm1 depletion SL RNA cap, permeabilized <br />                                           cells labeled [&#206;&#177;-32P]ATP order monitor status <span id='am-79' about='obo:IMR_0100126' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001697 obo:IMR_0000001 obo:IMR_0001698'><span id='am-80' property="oboInOwl:hasExactSynonym" content="Adenosine" datatype="xsd:string"></span><span id='am-81' property="rdfs:label" content="Adenine riboside" datatype="xsd:string"></span><span id='am-82' property="rdfs:label" content="adenosine" datatype="xsd:string"></span><span id='am-83' property="oboInOwl:hasDbXref" content="KEGG:C00212" datatype="xsd:string"></span><span id='am-84' property="oboInOwl:hasAlternativeId" content="IMR:0200246" datatype="xsd:string"></span><span id='am-85' property="oboInOwl:hasExactSynonym" content="Adenine riboside" datatype="xsd:string"></span><span id='am-86' property="oboInOwl:hasExactSynonym" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-87' property="obo:IAO_0000115" content="A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter." datatype="xsd:string"></span><span id='am-88' property="rdfs:label" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-89' property="oboInOwl:hasExactSynonym" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-90' property="oboInOwl:id" content="IMR:0100126" datatype="xsd:string"></span><span id='am-91' property="rdfs:label" content="Adenosine" datatype="xsd:string"></span><span id='am-92' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-93' property="rdfs:label" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span>adenosine</span> position <br />                                           1, e. initiating nucleotide, SL RNA. gel purified SL RNA digested                                           nuclease P1 (Fig. 5B) generates 5&#226;&#8364;&#178;nucleotide monophosphates, does cleave <br />                                           pyrophosphate bonds, e. cleave triphosphate bridge linking m7G                                           <span id='am-94' about='obo:IMR_0100126' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001697 obo:IMR_0000001 obo:IMR_0001698'><span id='am-95' property="oboInOwl:hasAlternativeId" content="IMR:0200246" datatype="xsd:string"></span><span id='am-96' property="rdfs:label" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-97' property="oboInOwl:id" content="IMR:0100126" datatype="xsd:string"></span><span id='am-98' property="rdfs:label" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-99' property="obo:IAO_0000115" content="A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter." datatype="xsd:string"></span><span id='am-100' property="rdfs:label" content="Adenosine" datatype="xsd:string"></span><span id='am-101' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-102' property="rdfs:label" content="Adenine riboside" datatype="xsd:string"></span><span id='am-103' property="oboInOwl:hasDbXref" content="KEGG:C00212" datatype="xsd:string"></span><span id='am-104' property="oboInOwl:hasExactSynonym" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-105' property="oboInOwl:hasExactSynonym" content="Adenine riboside" datatype="xsd:string"></span><span id='am-106' property="oboInOwl:hasExactSynonym" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-107' property="rdfs:label" content="adenosine" datatype="xsd:string"></span><span id='am-108' property="oboInOwl:hasExactSynonym" content="Adenosine" datatype="xsd:string"></span>adenosine</span> position 1. expected, sample prepared uninduced cells majority <br />                                           label (96%) comigrated AMP (lane 1). prominent spot (3%, designated <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           X2) did correspond available standards, decreased induction <br />                                           period 50% abundant 2.5 days. P1 digestion SL RNA labeled                                           [&#206;&#177;-32P]GTP generated identical spot (data shown) speculate                                           represents dinucleotide derived cap structure. addition, 0.7% radioactive <br />                                           label associated ATP, likely originates 5&#226;&#8364;&#178; end primary SL <br />                                           transcripts. Following 1 2.5 days TbCgm1 depletion level ATP did change <br />                                           significantly. fourth spot identified <span id='am-15' about='obo:IMR_0001360' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-16' property="oboInOwl:hasAlternativeId" content="IMR:0200375" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasDbXref" content="KEGG:C00008" datatype="xsd:string"></span><span id='am-18' property="rdfs:label" content="ADP" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:id" content="IMR:0001360" datatype="xsd:string"></span>ADP</span>. SL RNA uninduced cells <br />                                           0.2% radioactivity associated ADP, downregulation TbCGM1 1 2.5 <br />                                           days resulted gradual increase ADP reaching 0.5% 2.5 days. likely <br />                                           explanation result TbCgm1 depletion gave rise increase diphosphate- <br />                                           terminated RNA, e. capping transcripts blocked triphosphatase step, <br />                                           removed terminal phosphate primary transcript.  taken                                           observations provided supporting evidence TbCgm1 required capping SL <br />                                           RNA. <br />  <br />                               3.5. Trans-splicing utilization SL RNA reduced TbCgm1-depleted cells <br />                                           m7G cap determinants utilization SL RNA trans- <br />                                           splicing, examined trans-splicing activity TbCgm1-depleted cells (Fig. 4D). RNA <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           derived uninduced cells (lane 2), primer extension analysis produced cDNA <br />                                           corresponding length SL RNA, primer extension stop mapping 5&#226;&#8364;&#178; end <br />                                           SL intron, diagnostic Y-structures (SL RNA intron-pre-mRNA <br />                                           branched intermediates formed step trans-splicing). Y-structures                                           detectable cells treated sinefungin (lane 1), drug blocks trans-splicing                                           trypanosomes [45]. analysis TbCGM1 silencing reduced                                           accumulation Y-structures 35% 2.5 days induction (Fig. 4D, lane 5). <br />  <br />                               3.6. Recruitment TbCgm1 SL RNA genes <br />                                           provide independent evidence TbCgm1 involved maturation SL RNA, <br />                                           monitored vivo association polypeptide SL RNA genes using <br />                                           chromatin immunoprecipitation (ChIP). end, generated T. brucei cell line <br />                                           expressing solely epitope-tagged version TbCgm1. deleted allele homologous <br />  <br />  <br />                                             Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                                Page 7 <br />  <br />  <br />                                          recombination PCR-generated cassette encoding blasticidin resistance gene                                          introduced N-terminal BB2 epitope second allele original chromosomal locus. <br />                                          approach ensured epitope-tagged version protein functional NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          expressed levels comparable endogenous protein. addition, generated cell line <br />                                          solely expressing BB2 epitope-tagged TbCe1. previously shown ChIP pol II <br />                                          transcription factor TRF4 recruited SL RNA genes [37]. Using                                          protocol, TbCgm1 specifically associated SL RNA genes (Fig. 6, lane 6), <br />                                          upstream control region (lane 3). contrast, did detect recruitment                                          TbCe1 SL RNA genes (lane 12). result corroborated RNAi permeable cell <br />                                          experiments supported conclusion TbCgm1 plays role capping                                          SL RNA. <br />  <br />                               4. Discussion <br />                                          Eukaryotes rely enzymatic reactions formation m7GpppN cap,                                          sequential action RNA 5&#226;&#8364;&#178; triphosphatase, RNA guanylyltransferase RNA (guanine- <br />                                          N7) methyltransferase. physical organization capping apparatus quite <br />                                          distinct different taxa [4,8,9], enzymatic activity assigned single polypeptide <br />                                          domain. contrast, distinct novel genetic organization emerging                                          trypanosomatids, presence guanylyltransferase domains: (TbCe1) fused <br />                                          N-terminal domain unknown function [27] second (TbCgm1) C-terminal <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          (guanine-N7) methyltransferase [29,30]. addition, separate RNA triphosphatase, <br />                                          mechanistically related fungal enzymes [28,46], separate (guanine-N7) <br />                                          methyltransferase [29]. polypeptides characterized <br />                                          biochemically shown involved m7G capping, challenge remains assign                                          vivo functions. taken step goal analyzed functional <br />                                          consequences TbCe1 TbCgm1 downregulation. Surprisingly, RNAi downregulation                                          Ce1 phenotypic consequences, precluding investigations route. <br />                                           interpret result mean TbCe1 needed capping                                          trypanosomes. RNAi does generate &#226;&#8364;&#339;knockout&#226;&#8364;?, downregulates mRNA <br />                                          levels, likely explanation residual TbCe1 protein sufficient <br />                                          cell growth.  far able generate &#226;&#8364;&#339;classical&#226;&#8364;? TbCE1 knockout <br />                                          strain, alleles gene replaced antibiotic resistance marker, <br />                                          indicating gene likely essential.  vivo function TbCe1 <br />                                          remains determined. <br />  <br />                                          shown presence diagnostic motifs [29] mutagenesis analysis, TbCgm1 <br />                                          hallmarks activity RNA guanylyltransferase. contrast negative <br />                                          results obtained RNAi downregulation CE1, silencing CGM1 severe <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          consequences cell viability SL RNA capping: 2 3 days RNAi <br />                                          induction cells stopped growing demonstrating Cgm1 function essential cell <br />                                          viability. result similar observed yeast S. cerevisiae,                                          originally shown Ceg1, gene encoding capping enzyme, essential [7].                                          time interval cell growth begins slow  observed anomalies                                          regard SL RNA.  steady-state level SL RNA decreased substantially.                                          effect instability SL RNA molecules unmethylated cap <br />                                          result inhibition trans-splicing, likely cause havoc                                          cells. Second, accumulation molecules bearing hypomodified cap 4 structure. <br />                                          explanation finding likely lies requirement m7G cap                                          biogenesis cap 4 structure.  vaccinia virus steps biosynthesis                                          cap occur unique sequence, e. modification nucleotide adjacent cap <br />                                          requires m7G cap place [47].  CGM1 silencing proportion SL <br />                                          RNA bearing methylated cap substantially decreased, assessed antibody <br />  <br />  <br />                                            Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                                               Page 8 <br />  <br />  <br />                                          immunoprecipitation steady-state SL RNA TAP digestion newly&#226;&#8364;&#8220;synthesized SL <br />                                          RNA. Lastly, P1 digestion TLC analysis showed accumulation newly- <br />                                          synthesized SL RNA molecules ADP terminus. summary, results showed NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Cgm1 depletion results defects addition GMP methylation N7 <br />                                          position guanine. basis analyses, propose guanylyltransferase <br />                                          domain TbCgm1 responsible adding GMP diphosphate terminated SL RNA. <br />                                          Activity assays recombinant protein corroborated proposed function domain. <br />                                          Furthermore, observation relative m7G cap decreased, consequence <br />                                          TbCgm1 depletion, concomitant increase unmethylated GMP cap, provides <br />                                          evidence polypeptide required methylation step capping reaction. <br />                                          far, able produce putative C-terminal (guanine-N7) <br />                                          methyltransferase domain recombinant form test proposed enzymatic activity.                                          manuscript preparation, Ho laboratory reported recombinant TbCgm1                                          bifunctional capping enzyme capable transferring GMP SL RNA covalent enzyme- <br />                                          GMP intermediate [30]. addition, shown TbCgm1 methylates guanine N-7 <br />                                          position GpppN-terminated RNA. Taken  results agreement                                          TbCgm1 responsible capping SL RNA. <br />  <br />                                          previously shown SL RNA transcripts short 30 nucleotides capped, <br />                                          consistent transcriptional mechanism m7G capping addition [3]. model                                          strengthened ChIP experiments presented  revealed vivo <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          association TbCgm1 SL RNA genes. remains explored                                          capping enzyme recruited transcriptional machinery. SL RNA genes                                          transcribed pol II [48], mechanism likely similar described yeast                                          mammals, physical interaction capping enzyme CTD                                          largest subunit pol II [49,50]. <br />  <br />                                          presence guanylyltransferase domains trypanosomatid protozoa unexpected <br />                                          far, best knowledge, reported eukaryotic organism. <br />                                          important bear mind capping organisms occurs pol II <br />                                          transcripts, SL RNA, specific subset pol III transcripts.                                          attractive possibility TbCe1 involved capping subset pol III transcripts.                                          TbCe1 directed U1, U2, U3 U4 snRNAs, abundant <br />                                          pol III transcripts, present matter speculation. pol III common                                          genes, possibilities consider specificity achieved gene- <br />                                          specific transcription factor(s), RNA determinants combination mechanisms. <br />  <br />                               Acknowledgments <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          thank Andrei Alexandrov help discussion TLC analysis. study received support National <br />                                          Institutes Health Grant AI43594 C.T. <br />  <br />  <br />                               References <br />                                          1. Rasmussen EB, Lis JT. vivo transcriptional pausing cap formation Drosophila heat <br />                                             shock genes. Proc Natl Acad Sci U S 1993;90:7923&#226;&#8364;&#8220;7. [PubMed: 8367444] <br />                                          2. Hagler J, Shuman S. freeze-frame view eukaryotic transcription elongation capping <br />                                             nascent mRNA. Science 1992;255:983&#226;&#8364;&#8220;6. [PubMed: 1546295] <br />                                          3. Mair G, Ullu E, Tschudi C. Cotranscriptional cap 4 formation Trypanosoma brucei spliced <br />                                             leader RNA. J Biol Chem 2000;275:28994&#226;&#8364;&#8220;9. [PubMed: 10880518] <br />                                          4. Shuman S. Structure, mechanism, evolution mRNA capping apparatus. Prog Nucleic Acid <br />                                             Res Mol Biol 2001;66:1&#226;&#8364;&#8220;40. [PubMed: 11051760] <br />  <br />  <br />  <br />  <br />                                            Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                                    Page 9 <br />  <br />  <br />                                          5. Shibagaki Y, Itoh N, Yamada H, Nagata S, Mizumoto K. mRNA capping enzyme. Isolation                                             characterization gene encoding mRNA guanylytransferase subunit Saccharomyces <br />                                             cerevisiae. J Biol Chem 1992;267:9521&#226;&#8364;&#8220;8. [PubMed: 1315757] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          6. Mao X, Schwer B, Shuman S. Yeast mRNA cap methyltransferase 50-kilodalton protein encoded <br />                                             essential gene. Mol Cell Biol 1995;15:4167&#226;&#8364;&#8220;74. [PubMed: 7623811] <br />                                          7. Tsukamoto T, Shibagaki Y, Imajoh-Ohmi S, Murakoshi T, Suzuki M, Nakamura  Gotoh H, <br />                                             Mizumoto K. Isolation characterization yeast mRNA capping enzyme beta subunit gene <br />                                             encoding RNA 5&#226;&#8364;&#178;-triphosphatase, essential cell viability. Biochem Biophys Res Commun <br />                                             1997;239:116&#226;&#8364;&#8220;22. [PubMed: 9345280] <br />                                          8. Shuman S. messenger RNA capping tells eukaryotic evolution. Nat Rev Mol Cell Biol <br />                                             2002;3:619&#226;&#8364;&#8220;25. [PubMed: 12154373] <br />                                          9. Shuman S, Lima CD. polynucleotide ligase RNA capping enzyme superfamily covalent <br />                                             nucleotidyltransferases. Curr Opin Struct Biol 2004;14:757&#226;&#8364;&#8220;64. [PubMed: 15582400] <br />                                          10. Ho CK, Shuman S. yeast-like mRNA capping apparatus Plasmodium falciparum. Proc Natl <br />                                              Acad Sci U S 2001;98:3050&#226;&#8364;&#8220;5. [PubMed: 11248030] <br />                                          11. Hausmann S, Altura MA, Witmer M, Singer SM, Elmendorf HG, Shuman S. Yeast-like mRNA <br />                                              capping apparatus Giardia lamblia. J Biol Chem 2005;280:12077&#226;&#8364;&#8220;86. [PubMed: 15556935] <br />                                          12. Hakansson K, Doherty AJ, Shuman S, Wigley DB. X-ray crystallography reveals large <br />                                              conformational change guanyl transfer mRNA capping enzymes. Cell 1997;89:545&#226;&#8364;&#8220;53. <br />                                              [PubMed: 9160746] <br />                                          13. Lima CD, Wang LK, Shuman S. Structure mechanism yeast RNA triphosphatase: essential <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              component mRNA capping apparatus. Cell 1999;99:533&#226;&#8364;&#8220;43. [PubMed: 10589681] <br />                                          14. Gong C, Shuman S. Chlorella virus RNA triphosphatase: mutational analysis mechanism                                              inhibition tripolyphosphate. J Biol Chem 2002;13:13. <br />                                          15. Takagi T, Moore CR, Diehn F, Buratowski S. RNA 5&#226;&#8364;&#178;-triphosphatase related protein tyrosine <br />                                              phosphatases. Cell 1997;89:867&#226;&#8364;&#8220;73. [PubMed: 9200605] <br />                                          16. Changela  Ho CK, Martins  Shuman S, Mondragon  Structure mechanism RNA <br />                                              triphosphatase component mammalian mRNA capping enzyme. EMBO J 2001;20:2575&#226;&#8364;&#8220;86. <br />                                              [PubMed: 11350947] <br />                                          17. Fabrega C, Hausmann S, Shen V, Shuman S, Lima CD. Structure mechanism mRNA cap <br />                                              (guanine-N7) methyltransferase. Mol Cell 2004;13:77&#226;&#8364;&#8220;89. [PubMed: 14731396] <br />                                          18. Murphy WJ, Watkins KP, Agabian N. Identification novel Y branch structure intermediate <br />                                              trypanosome mRNA processing: evidence trans splicing. Cell 1986;47:517&#226;&#8364;&#8220;25. [PubMed: <br />                                              3779835] <br />                                          19. Sutton  Boothroyd JC. Evidence trans splicing trypanosomes. Cell 1986;47:527&#226;&#8364;&#8220;35. <br />                                              [PubMed: 3022935] <br />                                          20. Laird PW, Zomerdijk JC, Korte D, Borst P. vivo labelling intermediates discontinuous <br />                                              synthesis mRNAs Trypanosoma brucei. EMBO J 1987;6:1055&#226;&#8364;&#8220;62. [PubMed: 3595556] <br />                                          21. Bangs JD, Crain PF, Hashizume T, McCloskey JA, Boothroyd JC. Mass spectrometry mRNA cap <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              4 trypanosomatids reveals novel nucleosides. J Biol Chem 1992;267:9805&#226;&#8364;&#8220;15. [PubMed: <br />                                              1349605] <br />                                          22. Arhin GK, Li H, Ullu E, Tschudi C. protein related vaccinia virus cap-specific <br />                                              methyltransferase VP39 involved cap 4 modification Trypanosoma brucei. RNA 2006;12:53&#226;&#8364;&#8220; <br />                                              62. [PubMed: 16301606] <br />                                          23. Arhin GK, Ullu E, Tschudi C. 2&#226;&#8364;&#178;-O-methylation position 2 trypanosome spliced leader cap <br />                                              4 mediated 48 kDa protein related vaccinia virus VP39. Mol Biochem Parasitol <br />                                              2006;147:137&#226;&#8364;&#8220;9. [PubMed: 16516986] <br />                                          24. Zamudio JR, Mittra B, Zeiner GM, Feder M, Bujnicki JM, Sturm NR, Campbell DA. Complete cap <br />                                              4 formation required viability Trypanosoma brucei. Eukaryot Cell 2006;5:905&#226;&#8364;&#8220;15. <br />                                              [PubMed: 16757738] <br />                                          25. Hall MP, Ho CK. Functional characterization 48 kDa Trypanosoma brucei cap 2 RNA <br />                                              methyltransferase. Nucleic Acids Res 2006;34:5594&#226;&#8364;&#8220;602. [PubMed: 17028101] <br />                                          26. Li H, Tschudi C. Novel essential subunits 300-kilodalton nuclear cap binding complex                                              Trypanosoma brucei. Mol Cell Biol 2005;25:2216&#226;&#8364;&#8220;26. [PubMed: 15743819] <br />  <br />  <br />                                            Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                                   Page 10 <br />  <br />  <br />                                          27. Silva E, Ullu E, Kobayashi R, Tschudi C. Trypanosome capping enzymes display novel domain <br />                                              structure. Mol Cell Biol 1998;18:4612&#226;&#8364;&#8220;9. [PubMed: 9671471] <br />                                          28. Ho CK, Shuman S. Trypanosoma brucei RNA triphosphatase. Antiprotozoal drug target guide <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              eukaryotic phylogeny. J Biol Chem 2001;276:46182&#226;&#8364;&#8220;6. [PubMed: 11553645] <br />                                          29. Hall MP, Ho CK. Characterization Trypanosoma brucei RNA cap (guanine N-7) <br />                                              methyltransferase. RNA 2006;12:488&#226;&#8364;&#8220;97. [PubMed: 16431985] <br />                                          30. Takagi Y, Sindkar S, Ekonomidis D, Hall MP, Ho CK. Trypanosoma brucei encodes bifunctional <br />                                              capping enzyme essential cap 4 formation spliced leader RNA. J Biol Chem <br />                                              2007;282:15995&#226;&#8364;&#8220;6005. [PubMed: 17416901] <br />                                          31. Djikeng, ; Shen, S.; Tschudi, C.; Ullu, E. Analysis gene function Trypanosoma brucei using <br />                                              RNA interference.  Melville, S., editor. Parasite Genomics Protocols. Vol. 270. Humana Press <br />                                               2004. p. 287-97. <br />                                          32. Wirtz E, Leal S, Ochatt C, Cross GA. tightly regulated inducible expression conditional <br />                                              gene knock-outs dominant-negative genetics Trypanosoma brucei. Mol Biochem Parasitol <br />                                              1999;99:89&#226;&#8364;&#8220;101. [PubMed: 10215027] <br />                                          33. Arhin GK, Shen S, Ullu E, Tschudi C. PCR-based method gene deletion protein tagging <br />                                              Trypanosoma brucei. Methods Mol Biol 2004;270:277&#226;&#8364;&#8220;86. [PubMed: 15153634] <br />                                          34. Djikeng  Shi H, Tschudi C, Ullu E. RNA interference Trypanosoma brucei: cloning small <br />                                              interfering RNAs provides evidence retroposon-derived 24&#226;&#8364;&#8220;26-nucleotide RNAs. RNA <br />                                              2001;7:1522&#226;&#8364;&#8220;30. [PubMed: 11720282] <br />                                          35. Ullu E, Tschudi C. Permeable trypanosome cells model transcription trans- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              splicing. Nucleic Acids Res 1990;18:3319&#226;&#8364;&#8220;26. [PubMed: 2356121] <br />                                          36. Ullu E, Tschudi C. Trans splicing trypanosomes requires methylation 5&#226;&#8364;&#178; end spliced <br />                                              leader RNA. Proc Natl Acad Sci U S 1991;88:10074&#226;&#8364;&#8220;8. [PubMed: 1719544] <br />                                          37. Ruan JP, Arhin GK, Ullu E, Tschudi C. Functional characterization Trypanosoma brucei TATA- <br />                                              binding protein-related factor points universal regulator transcription trypanosomes. Mol <br />                                              Cell Biol 2004;24:9610&#226;&#8364;&#8220;8. [PubMed: 15485927] <br />                                          38. Shi H, Djikeng  Mark T, Wirtz E, Tschudi C, Ullu E. Genetic interference Trypanosoma <br />                                              brucei heritable inducible double-stranded RNA. RNA 2000;6:1069&#226;&#8364;&#8220;76. [PubMed: <br />                                              10917601] <br />                                          39. Djikeng  Ferreira L, D&#226;&#8364;&#8482;Angelo M, Dolezal P, Lamb T, Murta S, Triggs V, Ulbert S, Villarino  <br />                                              Renzi SUE, Tschudi C. Characterization candidate Trypanosoma brucei U1 snRNA gene. Mol <br />                                              Biochem Parasitol 2001;113:91&#226;&#8364;&#8220;7. <br />                                          40. Tschudi C, Richards FF, Ullu E. U2 RNA analogue Trypanosoma brucei gambiense: <br />                                              implications splicing mechanism trypanosomes. Nucleic Acids Res 1986;14:8893&#226;&#8364;&#8220;903. <br />                                              [PubMed: 3786140] <br />                                          41. Mottram J, Perry KL, Lizardi PM, Luhrmann R, Agabian N, Nelson RG. Isolation sequence                                              small nuclear U RNA genes Trypanosoma brucei subsp. brucei: identification U2, U4, <br />                                              U6 RNA analogs. Mol Cell Biol 1989;9:1212&#226;&#8364;&#8220;23. [PubMed: 2725495] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          42. Gunzl  Bindereif  Ullu E, Tschudi C. Determinants cap trimethylation U2 small nuclear <br />                                              RNA conserved Trypanosoma brucei higher eukaryotic organisms. Nucleic <br />                                              Acids Res 2000;28:3702&#226;&#8364;&#8220;9. [PubMed: 11000261] <br />                                          43. Tschudi C, Ullu E. Unconventional rules small nuclear RNA transcription cap modification <br />                                              trypanosomatids. Gene Expr 2002;10:3&#226;&#8364;&#8220;16. [PubMed: 11868986] <br />                                          44. Mandelboim M, Estrano CL, Tschudi C, Ullu E, Michaeli S. role exon intron sequences <br />                                              trans-splicing utilization cap 4 modification trypanosomatid Leptomonas collosoma SL <br />                                              RNA. J Biol Chem 2002;277:35210&#226;&#8364;&#8220;8. [PubMed: 12121975] <br />                                          45. McNally KP, Agabian N. Trypanosoma brucei spliced-leader RNA methylations required                                              trans splicing vivo. Mol Cell Biol 1992;12:4844&#226;&#8364;&#8220;51. [PubMed: 1406666] <br />                                          46. Gong C, Martins  Shuman S. Structure-function analysis Trypanosoma brucei RNA <br />                                              triphosphatase evidence metal mechanism. J Biol Chem 2003;278:50843&#226;&#8364;&#8220;52. <br />                                              [PubMed: 14525979] <br />                                          47. Barbosa E, Moss B. mRNA(<span id='am-67' about='obo:IMR_0001697' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-68' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-69' property="rdfs:label" content="nucleoside" datatype="xsd:string"></span><span id='am-70' property="oboInOwl:hasDbXref" content="CHEBI:25611" datatype="xsd:string"></span><span id='am-71' property="oboInOwl:id" content="IMR:0001697" datatype="xsd:string"></span>nucleoside</span>-2&#226;&#8364;&#178;-)-methyltransferase vaccinia virus. Characteristics <br />                                              substrate specificity. J Biol Chem 1978;253:7698&#226;&#8364;&#8220;702. [PubMed: 701282] <br />  <br />  <br />                                            Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                               Page 11 <br />  <br />  <br />                                          48. Gilinger G, Bellofatto V. Trypanosome spliced leader RNA genes contain identified RNA <br />                                              polymerase II gene promoter organisms. Nucleic Acids Res 2001;29:1556&#226;&#8364;&#8220;64. [PubMed: <br />                                              11266558] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          49. Cho EJ, Takagi T, Moore CR, Buratowski S. mRNA capping enzyme recruited transcription <br />                                              complex phosphorylation RNA polymerase II carboxy-terminal domain. Genes Dev <br />                                              1997;11:3319&#226;&#8364;&#8220;26. [PubMed: 9407025] <br />                                          50. McCracken S, Fong N, Rosonina E, Yankulov K, Brothers G, Siderovski D, Hessel  Foster S, <br />                                              Program AE, Shuman S, Bentley DL. 5&#226;&#8364;&#178;-Capping enzymes targeted pre-mRNA binding                                              phosphorylated carboxy-terminal domain RNA polymerase II. Genes Dev 1997;11:3306&#226;&#8364;&#8220;18. <br />                                              [PubMed: 9407024] <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                       Page 12 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 1. <br />                                          guanylyltransferase domain TbCgm1 binds GMP. Soluble protein lysates bacteria <br />                                          expressing NusA protein (pET-44, lane 1), amino acids 1 - 785 TbCgm1 fused NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          NusA protein (wt, lane 2), fusion protein indicated mutation (K127A, lane 3) <br />                                          fractionated SDS-PAGE stained Coomassie blue dye (upper panel) tested <br />                                          GMP binding (lower panel, autoradiograph shown). sizes  kilodaltons)                                          marker proteins shown right position NusA-TbCgm1 fusion proteins <br />                                          indicated arrow. <br />  <br />  <br />  <br />  <br />                                            Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                         Page 13 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 2. <br />                                          RNAi-induced downregulation TbCE1 TbCGM1.   independent clonal cell lines <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          expressing TbCE1 dsRNA grown absence (lanes 1 3) presence (lanes 2                                          4) 24 hr total cell extracts assayed enzyme-GMP complex formation. (B)                                          assay panel  , TbCGM1 downregulated (lanes 2 4). (C) Cell <br />                                          densities measured 24, 48, 72, 90 96 hr induction RNAi tetracycline                                          clonal cell line expressing double-stranded RNA TbCE1 TbCGM1.                                          growth curves uninduced cells essentially identical wild-type cells (wt),                                          represented  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                            Page 14 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 3. <br />                                          TbCE1 downregulation RNAi.   Total RNA isolated uninduced (lanes 1&#226;&#8364;&#8220;5)                                          TbCE1-RNAi cells induced 8 days (lanes 6&#226;&#8364;&#8220;10) immunoprecipitated anti-m7G <br />                                          anti-TMG antibodies input  , supernatant (S) pellet (P) fractions assayed <br />                                          primer extension U2 snRNA (U2) U3 snoRNA (U3). (B) TbCE1 RNAi cell <br />                                          line induced tet indicated number days (lanes 2&#226;&#8364;&#8220;4) total RNA                                          assayed primer extension SL intron-specific primer. position fully-modified <br />                                          (fm SL) hypomodified (hm SL) SL RNA indicated. RNA isolated sinefungin- <br />                                          treated cells served control hypomodified SL RNA (lane 1). U6 snRNA-specific <br />                                          primer included reactions control RNA amounts quality. <br />  <br />                                            Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                         Page 15 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 4. <br />                                          TbCGM1 depletion affects SL RNA capping.   Total RNA isolated uninduced (lanes <br />                                          1&#226;&#8364;&#8220;5) TbGM1-RNAi cells induced 2.5 days (lanes 6&#226;&#8364;&#8220;10) immunoprecipitated                                          anti-m7G anti-TMG antibodies input  , supernatant (S) pellet (P) fractions <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          assayed primer extension U2 snRNA (U2) U3 snoRNA (U3). (B)                                          TbCGM1 RNAi cell line induced tet indicated number days (lanes 2&#226;&#8364;&#8220;5)                                          total RNA assayed primer extension SL intron-specific primer. position <br />                                          fully-modified (fm SL) hypomodified (hm SL) SL RNA indicated. RNA isolated <br />                                          sinefungin-treated cells served control hypomodified SL RNA (lane 1). U6 <br />                                          snRNA-specific primer included reactions control RNA amounts quality. <br />                                          (C) Total RNA isolated uninduced cells (lanes 1&#226;&#8364;&#8220;3) cells depleted TbCgm1 <br />                                          2.5 days (lanes 4&#226;&#8364;&#8220;6) immunoprecipitated anti-m7G antibodies input  , <br />                                          supernatant (S) pellet (P) fractions assayed primer extension SL intron- <br />                                          specific primer. U6-snRNA-specific primer included reactions control                                          immunoprecipitation specificity (U6). (D) Primer extension total RNA                                          oligonucleotide complementary nt 110 131 SL RNA. position Y-structure <br />                                          intermediate (Y) length SL RNA (SL) indicated. RNA isolated sinefungin- <br />  <br />  <br />  <br />                                            Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                            Page 16 <br />  <br />  <br />                                          treated cells used control trans-splicing inhibition (lane 1). oligonucleotide <br />                                          complementary U2 snRNA included loading quality control (U2). <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6. <br />                             Ruan et al.                                                                                          Page 17 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 5. <br />                                          Newly-synthesized RNA labeled [&#206;&#177;-32P]GTP [&#206;&#177;-32P]ATP prepared                                          permeabilized cells, spliced leader RNA gel purified analyzed tobacco acid <br />                                          pyrophosphatase P1 digestion. panels, SL RNA isolated uninduced <br />                                          cells (lane 1), cells depleted TbCGM1 1 day (lane 2) 2.5 days (lane 3).   <br />                                          cap nucleotide visualized digesting [&#206;&#177;-32P]GTP-labeled SL RNA tobacco <br />                                          acid pyrophosphatase TLC separation. positions nonradioactive m7Gp Gp <br />                                          markers (visualized UV light) indicated. (B) [&#206;&#177;-32P]ATP-label <br /> </body></html>